Search

everythinglearnresearchcommunity

for

Search:↓

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

New findings may help diagnose and understand scarring alopecia better.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Adalimumab may cause severe hair loss in some patients.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

PRP therapy with specific growth factors improves hair density and thickness in androgenic alopecia.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The most common causes of hair loss in children in South-East Nigeria are fungal infections and alopecia areata.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.